Pediatric small intestine bacterial overgrowth in low-income countries

Trends in Molecular Medicine

Volumn 21, Issue 1, 2015, Pages 6-15

  Donowitz, Jeffrey R ^a   Petri, William A ^b  

^a Children's Hospital of Richmond   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Celiac disease; Commensal bacteria; Environmental enteropathy; Malnutrition; Oral vaccine failure; Small intestine bacterial overgrowth

Indexed keywords

CHOLERA VACCINE; ORAL POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; TRACE ELEMENT; WATER;

BACTERIAL OVERGROWTH; CELIAC DISEASE; CHILD DEVELOPMENT; CHILD GROWTH; CHILDHOOD DISEASE; COMMENSAL; DISEASE ASSOCIATION; DISEASE COURSE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL MOTILITY DISORDER; HABITAT; HUMAN; LOWEST INCOME GROUP; MUCOSAL IMMUNITY; PEDIATRICS; PERMEABILITY; REGULATORY MECHANISM; REVIEW; SANITATION; SMALL INTESTINE BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; VACCINATION; VACCINE FAILURE; BACTERIUM; CHILD; DEVELOPING COUNTRY; ECONOMICS; FEMALE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; MALE; MICROBIOLOGY; MICROFLORA; PRESCHOOL CHILD; SMALL INTESTINE;

BACTERIA (MICROORGANISMS);

BACTERIA; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; FEMALE; HUMANS; INTESTINE, SMALL; MALE; MICROBIOTA;

EID: 84927694924     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2014.11.001     Document Type: Review

References (95)

1. O'Mahony S., Shanahan F. Enteric microbiota and small intestinal bacterial overgrowth. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010, 1769-1778. Saunders. M. Feldman (Ed.).
2. Wang M., et al. Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol. Ecol. 2005, 54:219-231.
3. Mello C.S., et al. Methane production and small intestinal bacterial overgrowth in children living in a slum. World J. Gastroenterol. 2012, 18:5932.
4. dos Reis J.C., et al. Breath hydrogen test in the diagnosis of environmental enteropathy in children living in an urban slum. Dig. Dis. Sci. 2007, 52:1253-1258.
5. Pereira S.P., et al. A pattern of breath hydrogen excretion suggesting small bowel bacterial overgrowth in Burmese village children. J. Pediatr. Gastroenterol. Nutr. 1991, 13:32-38.
6. Khin-Maung U., et al. Epidemiology of small bowel bacterial overgrowth and rice carbohydrate malabsorption in Burmese (Myanmar) village children. Am. J. Trop. Med. Hyg. 1992, 47:298-304.
7. Khin-Maung U., et al. Malabsorption of carbohydrate from rice and child growth: a longitudinal study with the breath-hydrogen test in Burmese village children. Am. J. Clin. Nutr. 1990, 52:348-352.
8. Lagos R., et al. Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. J. Infect. Dis. 1999, 180:1709-1712.
9. Riordan S., et al. Luminal bacteria and small-intestinal permeability. Scand. J. Gastroenterol. 1997, 32:556-563.
10. Miele L., et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009, 49:1877-1887.
11. Rubio-Tapia A., et al. Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J. Clin. Gastroenterol. 2009, 43:157-161.
12. 2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment. Pharmacol. Ther. 2009, 29(Suppl. 1):1-49.
13. Tahan S., et al. Effectiveness of trimethoprim-sulfamethoxazole and metronidazole in the treatment of small intestinal bacterial overgrowth in children living in a slum. J. Pediatr. Gastroenterol. Nutr. 2013, 57:316-318.
14. Parodi A., et al. Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am. J. Gastroenterol. 2008, 103:1257-1262.
15. Cuoco L., et al. Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics. Hepatogastroenterology 2002, 49:1582-1586.
16. Soudah H.C., et al. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N. Engl. J. Med. 1991, 325:1461-1467.
17. Rahman M., et al. Nitric oxide-mediated disorganisation of migrating myoelectric complex induced by diarrheogenic E. coli toxin. J. Gastrointest. Motil. 1993, 5:212-218.
18. Cullen J.J., et al. The effect of endotoxin on canine jejunal motility and transit. J. Surg. Res. 1997, 67:54-57.
19. Husebye E., et al. Intestinal microflora stimulates myoelectric activity of rat small intestine by promoting cyclic initiation and aboral propagation of migrating myoelectric complex. Dig. Dis. Sci. 1994, 39:946-956.
20. Husebye E., et al. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280:G368-G380.
21. Husebye E., et al. Abnormal intestinal motor patterns explain enteric colonization with Gram-negative bacilli in late radiation enteropathy. Gastroenterology 1995, 109:1078-1089.
22. Taniuchi M., et al. Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. J. Infect. Dis. 2013, 208:1794-1802.
23. Ngure F.M., et al. Formative research on hygiene behaviors and geophagy among infants and young children and implications of exposure to fecal bacteria. Am. J. Trop. Med. Hyg. 2013, 89:709-716.
24. Campbell D.I., et al. Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier function, leading to endotoxemia and systemic inflammation. J. Nutr. 2003, 133:1332-1338.
25. Brandt L.J., et al. Production of vitamin B12 analogues in patients with small-bowel bacterial overgrowth. Ann. Intern. Med. 1977, 87:546-551.
26. Welkos S.L., et al. Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome. Gastroenterology 1981, 80:313-320.
27. Giannella R., et al. Competition between bacteria and intrinsic factor for vitamin B 12: implications for vitamin B12 malabsorption in intestinal bacterial overgrowth. Gastroenterology 1972, 62:255-260.
28. Tabaqchali S., et al. Bile-salt deconjugation and steatorrhoea in patients with the stagnant-loop syndrome. Lancet 1968, 292:12-16.
29. Rosenberg I., et al. Abnormal bile-salt patterns and intestinal bacterial overgrowth associated with malabsorption. N. Engl. J. Med. 1967, 276:1391-1397.
30. Lee W.B., et al. Ocular complications of hypovitaminosis a after bariatric surgery. Ophthalmology 2005, 112:1031-1034.
31. Di Stefano M., et al. Small intestine bacterial overgrowth and metabolic bone disease. Dig. Dis. Sci. 2001, 46:1077-1082.
32. Schjønsby H. Osteomalacia in the stagnant loop syndrome. Acta Med. Scand. Suppl. 1977, 201:39-41.
33. Brin M.F., et al. Blind loop syndrome, vitamin E malabsorption, and spinocerebellar degeneration. Neurology 1985, 35:338-342.
34. Ramotar K., et al. Production of menaquinones by intestinal anaerobes. J. Infect. Dis. 1984, 150:213-218.
35. Conly J.M., Stein K. The production of menaquinones (vitamin K2) by intestinal bacteria and their role in maintaining coagulation homeostasis. Prog. Food Nutr. Sci. 1992, 16:307-343.
36. Parlesak A., et al. Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults. J. Am. Geriatr. Soc. 2003, 51:768-773.
37. Tabaqchali S., Pallis C. Reversible nicotinamide-deficiency encephalopathy in a patient with jejunal diverticulosis. Gut 1970, 11:1024-1028.
38. Lakhani S.V., et al. Small intestinal bacterial overgrowth and thiamine deficiency after roux-en-Y gastric bypass surgery in obese patients. Nutr. Res. 2008, 28:293-298.
39. Maxwell J., et al. Intestinal bypass in the rat: a model for growth failure, liver disease, and jejunal bacterial overgrowth in marasmus and kwashiorkor. J. Pediatr. Gastroenterol. Nutr. 1982, 1:417-426.
40. Fagundes-Neto U., et al. Studies of the small bowel surface by scanning electron microscopy in infants with persistent diarrhea. Braz. J. Med. Biol. Res. 2000, 33:1437-1442.
41. Jones E.A., et al. Protein metabolism in the intestinal stagnant loop syndrome. Gut 1968, 9:466-469.
42. Rutgeerts L., et al. Enterokinase in contaminated small-bowel syndrome. Digestion 1974, 10:249-254.
43. King C.E., Toskes P.P. Protein-losing enteropathy in the human and experimental rat blind-loop syndrome. Gastroenterology 1981, 80:504-509.
44. Jonas A., et al. Pathogenesis of mucosal injury in the blind loop syndrome. brush border enzyme activity and glycoprotein degradation. J. Clin. Invest. 1977, 60:1321-1330.
45. Giannella R.A., et al. Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome. Gastroenterology 1974, 67:965-974.
46. Toskes P., et al. Small intestinal mucosal injury in the experimental blind loop syndrome. Gastroenterology 1975, 68:1193-1203.
47. Riepe S.P., et al. Effect of secreted Bacteroides proteases on human intestinal brush border hydrolases. J. Clin. Invest. 1980, 66:314-322.
48. Omoike I., Abiodun P. Upper small intestinal microflora in diarrhea and malnutrition in Nigerian children. J. Pediatr. Gastroenterol. Nutr. 1989, 9:314-321.
49. Lunn P., et al. Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet 1991, 338:907-910.
50. Goto R., et al. Impact of intestinal permeability, inflammation status and parasitic infections on infant growth faltering in rural Bangladesh. Br. J. Nutr. 2009, 101:1509-1516.
51. Mondal D., et al. Contribution of enteric infection, altered intestinal barrier function, and maternal malnutrition to infant malnutrition in Bangladesh. Clin. Infect. Dis. 2012, 54:185-192.
52. Korpe P.S., Petri W.A. Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol. Med. 2012, 18:328-336.
53. Bauer T.M., et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am. J. Gastroenterol. 2002, 97:2364-2370.
54. Jiang N.M., et al. Febrile illness and pro-inflammatory cytokines are associated with lower neurodevelopmental scores in Bangladeshi infants living in poverty. BMC Pediatr. 2014, 14:50.
55. Mendez M.A., Adair L.S. Severity and timing of stunting in the first two years of life affect performance on cognitive tests in late childhood. J. Nutr. 1999, 129:1555-1562.
56. Berkman D.S., et al. Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet 2002, 359:564-571.
57. Peterson L.W., Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 2014, 14:141-153.
58. Fung T.C., et al. Anatomical localization of commensal bacteria in immune cell homeostasis and disease. Immunol. Rev. 2014, 260:35-49.
59. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 2008, 8:411-420.
60. Batt R.M., et al. Biochemical changes in the jejunal mucosa of dogs with a naturally occurring enteropathy associated with bacterial overgrowth. Gut 1984, 25:816-823.
61. Riordan S., et al. Mucosal cytokine production in small-intestinal bacterial overgrowth. Scand. J. Gastroenterol. 1996, 31:977-984.
62. Riordan S.M., et al. Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora. Am. J. Gastroenterol. 2001, 96:494-500.
63. Kett K., et al. Intestinal B-cell isotype response in relation to local bacterial load: evidence for immunoglobulin A subclass adaptation. Gastroenterology 1995, 109:819-825.
64. Riordan S., et al. Luminal immunity in small-intestinal bacterial overgrowth and old age. Scand. J. Gastroenterol. 1996, 31:1103-1109.
65. Quigley E.M., Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology 2006, 130:S78-S90.
66. Hooper L.V., et al. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 2002, 22:283-307.
67. Salyers A.A., et al. Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl. Environ. Microbiol. 1977, 33:319-322.
68. Mack D.R., et al. Extracellular MUC3 mucin secretion follows adherence of lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003, 52:827-833.
69. Mack D.R., et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 1999, 276:G941-G950.
70. Smirnova M.G., et al. LPS up-regulates mucin and cytokine mRNA expression and stimulates mucin and cytokine secretion in goblet cells. Cell. Immunol. 2003, 221:42-49.
71. Sherman P., et al. Bacteria and the mucus blanket in experimental small bowel bacterial overgrowth. Am. J. Pathol. 1987, 126:527-534.
72. Patriarca P.A., et al. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev. Infect. Dis. 1991, 13:926-939.
73. Simanjuntak C., et al. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet 1992, 340:689-694.
74. Gotuzzo E., et al. Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels. Infect. Immun. 1993, 61:3994-3997.
75. Hallander H., et al. Calibrated serological techniques demonstrate significant different serum response rates to an oral killed cholera vaccine between Swedish and Nicaraguan children. Vaccine 2002, 21:138-145.
76. Centers for Disease Control and Prevention Progress toward interruption of wild poliovirus transmission - worldwide, 2009. MMWR Morb. Mortal. Wkly. Rep. 2010, 59:545-550.
77. Centers for Disease Control and Prevention Progress toward poliomyelitis eradication - India, January 2007-May 2009. MMWR Morb. Mortal. Wkly. Rep. 2009, 58:719-723.
78. John T.J. Antibody response of infants in tropics to five doses of oral polio vaccine. Br. Med. J. 1976, 1:812.
79. Paul Y. Why polio has not been eradicated in India despite many remedial interventions?. Vaccine 2009, 27:3700-3703.
80. Patel M., et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009, 301:2243-2251.
81. Boom J.A., et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010, 125:e199-e207.
82. Zaman K., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:615-623.
83. Armah G.E., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:606-614.
84. John T.J. Oral polio vaccination of children in the tropics. II. Antibody response in relation to vaccine virus infection. Am. J. Epidemiol. 1975, 102:414-421.
85. Zaman K., et al. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine 2009, 27:1333-1339.
86. Domok I., et al. Factors affecting the efficacy of live poliovirus vaccine in warm climates. Efficacy of type 1 Sabin vaccine administered together with antihuman gamma-globulin horse serum to breast-fed and artificially fed infants in Uganda. Bull. World Health Organ. 1974, 51:333-347.
87. Cataldo F., Montalto G. Celiac disease in the developing countries: a new and challenging public health problem. World J. Gastroenterol. 2007, 13:2153.
88. Tursi A., et al. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am. J. Gastroenterol. 2003, 98:839-843.
89. Ghoshal U.C., et al. Partially responsive celiac disease resulting from small intestinal bacterial overgrowth and lactose intolerance. BMC Gastroenterol. 2004, 4:10.
90. Rana S., et al. Small intestinal bacterial overgrowth in north Indian patients with celiac disease. Trop. Gastroenterol. 2007, 28:159.
91. Cinova J., et al. Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free rats. PLoS ONE 2011, 6:e16169.
92. Riordan S.M., et al. Luminal antigliadin antibodies in small intestinal bacterial overgrowth. Am. J. Gastroenterol. 1997, 92:1335-1338.
93. Onis M.D., et al. Is malnutrition declining? An analysis of changes in levels of child malnutrition since 1980. Bull. World Health Organ. 2000, 78:1222-1233.
94. Trehan I., et al. Antibiotics as part of the management of severe acute malnutrition. N. Engl. J. Med. 2013, 368:425-435.
95. Parashar U.D., et al. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 2003, 9:565-572.